Content on PharmTech.com this week ranged from fundamentals on the use of digital pathology in drug development, discussions on the use of AI in pharma, and regulatory actions impacting the industry.
|Articles|March 2, 2019
- Pharmaceutical Technology-03-02-2019
- Volume 43
- Issue 3
Floor Mounted Walk-In Fume Hoods
UniFlow FM Fume Hoods by HEMCO are suited for synthesis, distillation, and other rack-type operations where a tall apparatus is used or equipment is rolled into the work area.
UniFlow FM Fume Hoods by HEMCO are suited for synthesis, distillation, and other rack-type operations where a tall apparatus is used or equipment is rolled into the work area.
The hoods have full 70-in. viewing height for ease of access and unobstructed view of fume chamber. Sizes include 48-, 60-, 72-, 96-, and 120-in. and depths of 30-, 36-, and 48-in. Features include double wall construction with an angled picture frame opening with either double vertical side sashes or horizontal sliding glass doors.
A removable upper-front panel allows access to ducting connections and electrical services from a single point electrical box, 115V60Hz AC operation. The varaflow baffle system maintains a uniform airflow to the bell-shaped exhaust collar. The hoods are available in standard or special sizes to meet various applications. Modular construction can be shipped disassembled for on-site assembly.
Articles in this issue
over 7 years ago
Tablet Press Refurbishment: Why and How?over 7 years ago
Embracing the Digital Factory for Bio/Pharma Manufacturingover 7 years ago
Caught in a Conundrumover 7 years ago
Strategic Screening for Solubility Solutionsover 7 years ago
Monoplant: Advantages of a Dedicated Facilityover 7 years ago
Handle with Careover 7 years ago
Rising to the Challenge of Biologic Drug Formulationover 7 years ago
Can the Price Ever be Right?over 7 years ago
Europe Pushes for Global Easing of Generics Approvalsover 7 years ago
Key Considerations in Stability TestingRelated to this article
This article discusses risk-based lifecycle governance, system implementation considerations, and the progression of batch record control from paper-based to fully electronic systems.
Ronald Piervincenzi, USP, explains why manufacturers should act now and how benchmarking could reward reliable generic drug suppliers.
The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Trending on Pharmaceutical Technology
1
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
2
PharmTech AI Pulse Check: Validating Multi-Agent Systems, OCR Models in GxP
3
CPHI Milan: USP Benchmarks Reshape Procurement Incentives
4
Pharma Fundamentals: Digital Pathology in Drug Development, Part 1
5